Literature DB >> 27430026

Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis.

Joseph J Fantony1, Ajay Gopalakrishna1, Megan Van Noord2, Brant A Inman1.   

Abstract

CONTEXT: Postcystectomy bladder cancer (BCa) patients are at high risk for developing venous thromboembolism (VTE). The literature varies widely in the reporting of VTE in this population.
OBJECTIVE: To determine the VTE rate in subjects undergoing radical cystectomy (RC) and highlight specific factors affecting this rate. EVIDENCE ACQUISITION: This meta-analysis was registered with the International Prospective Register of Systematic Reviews (PROSPERO) database, registration number: CRD42015016776. We queried MEDLINE, the Cochrane Library, Embase, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science. Search terms captured BCa, RC, and VTE. Per the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines, abstracts were reviewed for inclusion/exclusion criteria by two reviewers, and disagreements were resolved by a third reviewer. A search of the gray literature and references of pertinent articles was also performed. The date of our last search was December 15, 2014. For unreported data, authors were contacted. Data were abstracted in duplicate and pooled using a random effects (RE) model. Subgroup analyses and meta-regression were performed to determine risk factors for VTE. EVIDENCE SYNTHESIS: We identified 2927 publications, of which 223 met inclusion criteria for this review. A total of 1 115 634 surgeries were performed on patient population (80% men) with a total of 51 908 VTEs. The VTE rate estimated by the RE model was 3.7%. Due to significant heterogeneity, subgroup and meta-regression analyses were undertaken. These revealed a higher rate of VTE in US studies at 4.49% compared with "westernized" non-US studies at 3.43% and "nonwesternized" non-US based studies at 2.50%. Other important modifiers included minimally invasive surgery at 5.54% versus open surgery at 3.55%, and age. The case-fatality rate of pulmonary emboli was 44%.
CONCLUSIONS: VTE is common in patients undergoing RC. Reporting of VTE is heterogeneous and the rate varies according to study-level factors, including surgery type and country of origin. Limitations of this study include the preponderance of observational studies in the final analysis and lack of complete reporting of all variables of interest within each study. PATIENT
SUMMARY: In this review, we determined the venous thromboembolism (VTE) rate in postsurgical bladder cancer patients. VTE events did vary significantly among certain subgroups.

Entities:  

Keywords:  Bladder cancer; Cystectomy; Deep venous thrombosis; Pulmonary embolism; Venous thromboembolism

Year:  2015        PMID: 27430026      PMCID: PMC4941825          DOI: 10.1016/j.euf.2015.09.003

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  32 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Controlling the risk of spurious findings from meta-regression.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2004-06-15       Impact factor: 2.373

3.  Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.

Authors:  P Mismetti; S Laporte; J Y Darmon; A Buchmüller; H Decousus
Journal:  Br J Surg       Date:  2001-07       Impact factor: 6.939

Review 4.  The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies.

Authors:  Andra Morrison; Julie Polisena; Don Husereau; Kristen Moulton; Michelle Clark; Michelle Fiander; Monika Mierzwinski-Urban; Tammy Clifford; Brian Hutton; Danielle Rabb
Journal:  Int J Technol Assess Health Care       Date:  2012-04       Impact factor: 2.188

5.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

6.  Thirty-day case-fatality rates for pulmonary embolism in the elderly.

Authors:  R M Siddique; M I Siddique; A F Connors; A A Rimm
Journal:  Arch Intern Med       Date:  1996-11-11

7.  Application of smooth Teflon clip to inferior vena cava during radical cystectomy to prevent postoperative pulmonary embolism.

Authors:  R Witherington; J S Hortenstine
Journal:  Urology       Date:  1991-08       Impact factor: 2.649

8.  Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy.

Authors:  Tobias Maurer; Jean Maurer; Margitta Retz; Roger Paul; Niko Zantl; Jurgen E Gschwend; Uwe Treiber
Journal:  Urol Int       Date:  2009-06-08       Impact factor: 2.089

9.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

10.  A proposed method of bias adjustment for meta-analyses of published observational studies.

Authors:  Simon Thompson; Ulf Ekelund; Susan Jebb; Anna Karin Lindroos; Adrian Mander; Stephen Sharp; Rebecca Turner; Désirée Wilks
Journal:  Int J Epidemiol       Date:  2010-12-23       Impact factor: 7.196

View more
  2 in total

Review 1.  High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis.

Authors:  Ajay Gopalakrishna; Thomas A Longo; Joseph J Fantony; Uma Doshi; Michael R Harrison; Megan Van Noord; Brant A Inman
Journal:  Urol Oncol       Date:  2016-06-04       Impact factor: 3.498

Review 2.  Venous Thromboembolism Rate in Patients With Bladder Cancer According to the Type of Treatment: A Systematic Review.

Authors:  Omar Abdullah; Deepak Parashar; Israa J Mustafa; Annie M Young
Journal:  Cureus       Date:  2022-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.